- Report
- June 2023
- 130 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- February 2023
- 88 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- February 2023
- 100 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- August 2022
- 81 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- November 2023
- 103 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- July 2024
- 153 Pages
Global
From €3308EUR$3,613USD£2,818GBP
€3892EUR$4,250USD£3,316GBP
- Report
- October 2023
- 146 Pages
Global
From €3231EUR$3,528USD£2,752GBP
€3801EUR$4,150USD£3,238GBP
- Report
- October 2023
- 146 Pages
Global
From €3231EUR$3,528USD£2,752GBP
€3801EUR$4,150USD£3,238GBP
- Report
- March 2022
- 40 Pages
Vietnam
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
United States
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
South Korea
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
Russia
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
Japan
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
Ireland
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
Germany
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
France
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
China
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 40 Pages
Brazil
From €1374EUR$1,500USD£1,170GBP
- Report
- March 2022
- 80 Pages
Africa
From €1832EUR$2,000USD£1,560GBP
- Report
- April 2025
Global
From €8700EUR$9,500USD£7,412GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more